CAPITOL COUNSEL LLC
Lobbying for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA) · Represents pharmaceutical research and biotechnology companies
Legislative issues related to access to pharmaceuticals; Rebates in Medicaid and for dual-eligibles; Medicaid coverage issues; 340B Drug Program; Medicare Part B and D prescription drug reimbursement. Pharmacy Benefit Management Reform in Medicare Part D.
Monitor implementation of the 340B Prescription Drug Discount Program and implementation of the Inflation Reduction Act of 2022 (P.L. No: 117-169). Issues regarding FDA user fee programs. Pharmacy Benefit Management Reform. Public health issues impacting patient access to treatments.
Issues related to trade enforcement and protection. Issues related to TRIPS waivers (Trade-Related Aspects of Intellectual Property Rights).
Issues related to the FY26 National Defense Authorization Act.